CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy
CD Bioparticles launches new line of Agonist-Based Adjuvants to support researchers. CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce the launch of its new line of Agonist-Based Adjuvants to support researchers in various fields, including vaccines and immunotherapeutics. These new adjuvants are designed to...
0 التعليقات 0 المشاركات 886 مشاهدة 0 معاينة